PMV Pharmaceuticals to Participate in the Goldman Sachs Global Healthcare Conference
06 Giugno 2023 - 10:01PM
PMV Pharmaceuticals, Inc. (Nasdaq: PMVP), a precision oncology
company pioneering the discovery and development of small molecule,
tumor-agnostic therapies targeting p53, today announced that David
H. Mack, Ph.D., President & Chief Executive Officer of PMV
Pharmaceuticals, will participate in a fireside chat at the Goldman
Sachs Global Healthcare Conference taking place in Dana Point,
California June 12-15, 2023. The company will also be available to
meet one-on-one with institutional investors at the conference.
Details on the fireside chat can be found below.
Goldman Sachs
Global Healthcare Conference |
Date: |
Tuesday, June 13, 2023 |
Time: |
8 a.m. PDT |
|
|
About PMV Pharma
PMV Pharma is a precision oncology company pioneering the
discovery and development of small molecule, tumor-agnostic
therapies targeting p53. p53 mutations are found in approximately
half of all cancers. The field of p53 biology was established by
our co-founder Dr. Arnold Levine when he discovered the p53 protein
in 1979. Bringing together leaders in the field to utilize over
four decades of p53 biology, PMV Pharma combines unique biological
understanding with pharmaceutical development focus. PMV Pharma is
headquartered in Princeton, New Jersey. For more information,
please visit www.pmvpharma.com.
Contacts
Investor Contact:Winston KungPMV
Pharmaceuticals, Inc.investors@pmvpharma.com
Media Contact:Kathy VincentGreig
Communicationskathy@greigcommunications.com
Grafico Azioni PMV Pharmaceuticals (NASDAQ:PMVP)
Storico
Da Ago 2024 a Set 2024
Grafico Azioni PMV Pharmaceuticals (NASDAQ:PMVP)
Storico
Da Set 2023 a Set 2024